SCHEMBL13660355

SCHEMBL13660355

CCCCCCCCN1/C(=C/C=C/C=C/C=C/C2=[N+](CCCCCCCC)c3ccc4ccccc4c3C2(C)C)C(C)(C)c2c1ccc1ccccc21

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT1 Q99873 12/20 0.82
BLM P54132 2/20 0.78
MLNR O43193 1/20 0.74
NR1I2 O75469 1/20 0.74
PGR P06401 1/20 0.74
ADRB1 P08588 1/20 0.74
ADORA3 P0DMS8 1/20 0.74
CHRM1 P11229 1/20 0.74
DRD2 P14416 1/20 0.74
ADRA2B P18089 1/20 0.74
ADRA2C P18825 1/20 0.74
CHRM3 P20309 1/20 0.74
CNR1 P21554 1/20 0.74
DRD1 P21728 1/20 0.74
TBXA2R P21731 1/20 0.74
SLC6A2 P23975 1/20 0.74
HRH2 P25021 1/20 0.74
HTR2C P28335 1/20 0.74
BDKRB2 P30411 1/20 0.74
ADORA1 P30542 1/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL71573 1.00 PRMT1 (0.82) PRMT1BLMMLNRNR1I2PGR
SCHEMBL13628952 1.00 PRMT1 (0.82) PRMT1BLMMLNRNR1I2PGR
SCHEMBL13628951 1.00 PRMT1 (0.82) PRMT1BLMMLNRNR1I2PGR
SCHEMBL14124681 0.99 PRMT1 (0.84) PRMT1BLMMLNRNR1I2PGR
SCHEMBL13905973 0.99 PRMT1 (0.84) PRMT1BLMMLNRNR1I2PGR
SCHEMBL13528718 0.99 PRMT1 (0.84) PRMT1BLMMLNRNR1I2PGR
SCHEMBL821483 0.96 PRMT1 (0.90) PRMT1BLMMLNRNR1I2PGR
SCHEMBL14262459 0.96 PRMT1 (0.90) PRMT1BLMMLNRNR1I2PGR
SCHEMBL13813716 0.95 PRMT1 (0.91) PRMT1BLMMLNRNR1I2PGR
SCHEMBL13528730 0.95 PRMT1 (0.91) PRMT1BLMMLNRNR1I2PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090263744-A1 ETHYLENICALLY UNSATURATED COMPOUND, LIGHT SENSITIVE COMPOSITION, LIGHT SENSITIVE PLANOGRAPHIC PRINTING PLATE MATERIAL AND PRINTING PROCESS EMPLOYING THE SAME KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2009-10-22 US disclosed
US-20090087779-A1 PRINTING PLATE MATERIAL KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2009-04-02 US disclosed
US-7273692-B2 Planographic printing plate material and planographic printing plate preparing process KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2007-09-25 US disclosed
US-7220530-B2 Light sensitive planographic printing plate material KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2007-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090263744-A1 ETHYLENICALLY UNSATURATED COMPOUND, LIGHT SENSITIVE COMPOSITION, LIGHT SENSITIVE PLANOGRAPHIC PRINTING PLATE MATERIAL AND PRINTING PROCESS EMPLOYING THE SAME ELOVL1, ELOVL6, ELOVL3 PRMT1 4702/4885BLM 4578/4885MLNR 2485/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.